SHPAX vs. FBTTX
Compare and contrast key facts about Saratoga Health & Biotechnology Fund (SHPAX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX).
SHPAX is managed by Saratoga. It was launched on Jul 14, 1999. FBTTX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
SHPAX vs. FBTTX - Performance Comparison
Loading graphics...
SHPAX vs. FBTTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | 0.66% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -5.30% | 11.78% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 2.18% | 39.21% | 5.08% | 10.43% | -8.22% | -3.35% | 31.82% | 25.39% | -4.19% | 25.37% |
Returns By Period
In the year-to-date period, SHPAX achieves a 0.66% return, which is significantly lower than FBTTX's 2.18% return. Over the past 10 years, SHPAX has underperformed FBTTX with an annualized return of 7.03%, while FBTTX has yielded a comparatively higher 11.54% annualized return.
SHPAX
- 1D
- 1.81%
- 1M
- -5.10%
- YTD
- 0.66%
- 6M
- 9.79%
- 1Y
- 15.26%
- 3Y*
- 7.57%
- 5Y*
- 5.93%
- 10Y*
- 7.03%
FBTTX
- 1D
- 5.09%
- 1M
- -0.77%
- YTD
- 2.18%
- 6M
- 15.39%
- 1Y
- 55.03%
- 3Y*
- 20.14%
- 5Y*
- 8.63%
- 10Y*
- 11.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SHPAX vs. FBTTX - Expense Ratio Comparison
SHPAX has a 2.90% expense ratio, which is higher than FBTTX's 1.28% expense ratio.
Return for Risk
SHPAX vs. FBTTX — Risk / Return Rank
SHPAX
FBTTX
SHPAX vs. FBTTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saratoga Health & Biotechnology Fund (SHPAX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SHPAX | FBTTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.86 | 1.92 | -1.07 |
Sortino ratioReturn per unit of downside risk | 1.28 | 2.52 | -1.23 |
Omega ratioGain probability vs. loss probability | 1.16 | 1.32 | -0.16 |
Calmar ratioReturn relative to maximum drawdown | 1.89 | 3.13 | -1.25 |
Martin ratioReturn relative to average drawdown | 5.16 | 12.48 | -7.31 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SHPAX | FBTTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.86 | 1.92 | -1.07 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 0.37 | +0.05 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | 0.47 | -0.05 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.30 | 0.00 |
Correlation
The correlation between SHPAX and FBTTX is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
SHPAX vs. FBTTX - Dividend Comparison
SHPAX's dividend yield for the trailing twelve months is around 3.64%, more than FBTTX's 1.50% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SHPAX Saratoga Health & Biotechnology Fund | 3.64% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 1.50% | 1.53% | 6.41% | 0.93% | 0.00% | 21.60% | 8.79% | 7.10% | 2.64% | 0.00% | 0.00% | 5.42% |
Drawdowns
SHPAX vs. FBTTX - Drawdown Comparison
The maximum SHPAX drawdown since its inception was -69.50%, which is greater than FBTTX's maximum drawdown of -63.75%. Use the drawdown chart below to compare losses from any high point for SHPAX and FBTTX.
Loading graphics...
Drawdown Indicators
| SHPAX | FBTTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.50% | -63.75% | -5.75% |
Max Drawdown (1Y)Largest decline over 1 year | -7.87% | -13.58% | +5.71% |
Max Drawdown (5Y)Largest decline over 5 years | -16.32% | -36.64% | +20.32% |
Max Drawdown (10Y)Largest decline over 10 years | -28.05% | -39.04% | +10.99% |
Current DrawdownCurrent decline from peak | -5.31% | -2.61% | -2.70% |
Average DrawdownAverage peak-to-trough decline | -28.07% | -21.95% | -6.12% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.88% | 3.72% | -0.84% |
Volatility
SHPAX vs. FBTTX - Volatility Comparison
The current volatility for Saratoga Health & Biotechnology Fund (SHPAX) is 5.09%, while Fidelity Advisor Biotechnology Fund Class M (FBTTX) has a volatility of 9.37%. This indicates that SHPAX experiences smaller price fluctuations and is considered to be less risky than FBTTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SHPAX | FBTTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.09% | 9.37% | -4.28% |
Volatility (6M)Calculated over the trailing 6-month period | 9.90% | 17.02% | -7.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.63% | 25.99% | -9.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.21% | 23.31% | -9.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.57% | 24.58% | -8.01% |